In primary samples of B cell lymphoma, miR-342 was found to be silenced by hyper methylation of the promoter region of the EVL gene, and 5-AzadC treatment resulted in re-expression of miR-342-3p and EVL protein. The gene discussed is EVL; the disease is B-cell non-Hodgkin lymphoma.